HYUNDAI BIOLAND Co., Ltd.
🇰🇷South Korea
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 3
1 (50.0%)RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)
Not Applicable
Not yet recruiting
- Conditions
- Guided Bone Regeneration
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Hyundai Bioland Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT06570265
Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
Phase 3
Completed
- Conditions
- Chondral or Osteochondral Lesion of Talus
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Hyundai Bioland Co., Ltd.
- Target Recruit Count
- 102
- Registration Number
- NCT04310215
- Locations
- 🇰🇷
Kyunghee University Medical Center, Seoul, Dongdaemun-gu, Korea, Republic of
🇰🇷Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
News
No news found